Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 603 50 612.7 |
| 96 | EP file number | EAKZ | 14 18 9022.8 |
| 97 | EP publication number | EPN | 2915533 |
| 54 | Designation/title | TI | Pharmazeutische Zusammensetzungen zur Behandlung von Krebs |
| 51 | IPC main class | ICM
(ICMV) | A61K 31/454 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/573 (2006.01), A61P 35/00 (2006.01) |
| 22 | DE application date | DAT | May 16, 2003 |
| 96 | EP application date | EAT | May 16, 2003 |
| 43 | Date of first publication | OT | Sep 9, 2015 |
| Date of publication of grant | PET | Sep 13, 2017 |
| 71/73 | Applicant/owner | INH | Celgene Corporation, Summit, N.J., US |
| 72 | Inventor | IN | Zeldis, Jerome B., Princeton, NJ New Jersey 08540, US |
| 74 | Representative | VTR | Jones Day Rechtsanwälte Patentanwälte, 80538 München, DE |
| Address for service | | JONES DAY Rechtsanwälte Patentanwälte, 80538 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
380842 P
May 17, 2002
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
424600 P
Nov 6, 2002
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002915533
Searchable text:
EP000002915533
Original document:
EP000002915533B1
Searchable text:
EP000002915533B1 |
| 43 | Date of first publication | EVT | Sep 9, 2015 |
| Date of the first transfer into DPMAregister | EREGT | Sep 10, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 23, 2018
(Show all update days)(Hide all update days)- Jan 23, 2018; Jan 4, 2018; Nov 4, 2017; Oct 26, 2017; Sep 15, 2017; Sep 14, 2017; Apr 27, 2017
- Historical data not available for this/these date(s)
- Sep 10, 2015
- Date of the first transfer into DPMAregister
|
